Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: JoeinIowa who wrote (2774)	8/12/2003 9:27:32 AM
From: Sergio H	Respond to of 23958

Joe, Ken is experimenting with holding one for the long haul right now. We've got two stocks in our folio featured in Briefing's IN PLAY this morning; CDIC and PCYC. CDIC happens to be Ken's hold <ggg>. B. Riley we know from a previous stock...don't we? Anyway, they're agreeing with us. Basically, CDIC has everything in place to improve earnings. Their target is a little more optimistic than I had in mind (71% growth). <8:37AM CardioDynamics started with a Buy at B. Riley (CDIC) 3.54: B. Riley initiates coverage of CDIC with a Buy rating and $5.06 target; firm thinks the co's capital equipment segment will continue to be the major rev contributor and that the sensors biz (the source of recurring rev) will experience rapid growth of about 71% YoY; also, building strategic partnerships with co's that have a large distribution arm or a complementary product should allow CDIC to achieve its goal of increased market penetration.> PCYC's news: <8:10AM Pharmacyclics announces presentation of Xcytrin data (PCYC) 4.51: The Co announced its data from its Phase 3 clinical trial of Xcytrin Injection for the treatment of brain metastases was presented at the 10th World Conference of the International Association for the Study of Lung Cancer. > Also, we've got IDEV's earnings. Now if IDEV comes out with a marketing deal.... Looking for more, but Yeehaw on CRV!